On Wednesday, June 5, The Heart.org posted this entry, "Rivaroxaban Cuts Stroke Risk in Sinus-Rhythm Heart Failure: COMMANDER-HF." (Click or Tap).
Posts - Anticoagulant Therapy
Mar 12, 2019 6:13pm
We hope that you've taken the opportunity to respond to our specimen integrity survey, which remains open for a few more days.
Mar 6, 2019 7:54am
The Heart.Org reports that the the Rivaroxaban and Apixaban reversal agent Andexxa (andexanet alpha) has earned conditional approval by the European Medicines Agency. Click or tap here for details.